Skip to search formSkip to main contentSkip to account menu

ARC 1779

Known as: ARC-1779, ARC1779 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Aptamers, Nucleotide
ULvWF Multimer-targeting Agent ARC1779

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Régulation de la fonction plaquettaire par un aptamère dirigé contre le domaine A1 du facteur Von-Willebrand
L’adhesion, l’activation et l’agregation des plaquettes representent les etapes initiales dans la formation du thrombus aux sites… 
Review
2010
Review
2010
FDA Pipeline preview, April 2010 (Miglustat, Insulin human inhalation powder, APF530, Exenatide LAR, Pirfenidone, ACU-4429, L-asparaginase, Alpha1-proteinase inhibitor, LIPO-102, QPI-1002/I5NP, MA09…
Recent FDA action (through March 2010) related to Miglustat, Insulin human inhalation powder, APF530, Exenatide LAR, Pirfenidone… 
2009
2009
ARC-1779, a PEGylated aptamer antagonist of von Willebrand factor for potential use as an anticoagulant or antithrombotic agent.
  • B. Cosmi
  • Current opinion in molecular therapeutics (Print)
  • 2009
  • Corpus ID: 37695719
Archemix Corp's ARC-1779 is an optimized, second-generation, PEGylated aptamer that exerts a novel antithrombotic action through… 
2008
2008
Gateways to clinical trials.
(-)-Epigallocatechin gallate, (-)-Gossypol; Ad.hIFN-beta, AF-37702, Agatolimod sodium, Agomelatine, Alvocidib hydrochloride, ARC… 
2007
2007
Abstract 3218: Pharmacokinetics, Pharmacodynamics, and Safety of an Anti-von Willebrand Factor Therapeutic Aptamer, ARC1779, in Healthy Volunteers
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)